Literature DB >> 33678305

Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU.

Hailin Zhao1, Roger Davies2, Daqing Ma3.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; critical care; dexmedetomidine; multi-organ dysfunction

Year:  2020        PMID： 33678305     DOI： 10.1016/j.bja.2020.09.031

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  6 in total

Review 1.  The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.

Authors:  Qin Ning; Di Wu; Xiaojing Wang; Dong Xi; Tao Chen; Guang Chen; Hongwu Wang; Huiling Lu; Ming Wang; Lin Zhu; Junjian Hu; Tingting Liu; Ke Ma; Meifang Han; Xiaoping Luo
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

2.  Post-operative Non-sustained Ventricular Tachycardia in a COVID-19 Positive Patient After Ketamine and Dexmedetomidine Infusion.

Authors:  Vandana Sharma; Muhammad Sarwar; Evin Koleini
Journal:  Cureus       Date:  2021-12-09

3.  Breathing face down.

Authors:  Massimo Lamperti; Luciano Gattinoni
Journal:  Br J Anaesth       Date:  2022-02-23       Impact factor: 11.719

4.  Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units.

Authors:  Amit Jain; Massimo Lamperti; D John Doyle
Journal:  Br J Anaesth       Date:  2020-10-14       Impact factor: 9.166

5.  The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19.

Authors:  John L Hamilton; Mona Vashi; Ekta B Kishen; Louis F Fogg; Markus A Wimmer; Robert A Balk
Journal:  Front Med (Lausanne)       Date:  2022-01-04

6.  Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill Covid-19 patients: A retrospective cohort study.

Authors:  Panu Uusalo; Mika Valtonen; Mikko J Järvisalo
Journal:  Acta Anaesthesiol Scand       Date:  2021-08-22       Impact factor: 2.274
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.